Expand VOR Menu
VOR MENU

VOR Latest Press Releases

-- June 8, 2026 --

Telitacicept Receives NMPA Approval for the Treatment of Sjgren's Disease in China Globe Newswire 8:31 AM
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China Globe Newswire 8:30 AM

-- June 1, 2026 --

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:00 PM

-- May 28, 2026 --

Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference Globe Newswire 8:30 AM

-- May 14, 2026 --

Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine Globe Newswire 8:30 AM

-- May 13, 2026 --

Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:30 AM

-- May 4, 2026 --

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- April 1, 2026 --

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:00 PM

-- March 30, 2026 --

Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Globe Newswire 8:01 AM
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjgren's Disease Globe Newswire 8:00 AM

-- March 27, 2026 --

Vor Bio Announces $75 Million Private Placement with TCGX Globe Newswire 8:00 AM

-- March 23, 2026 --

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:30 PM

-- February 23, 2026 --

Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes